Product Description
Abstract: Desvenlafaxine succinate (DVS) is one of several serotonin-norepinephrine reuptake inhibitors (SNRIs). Others are venlafaxine hydrochloride, milnacipran, and duloxetine. Desvenlafaxine has been approved by the US Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) based on a number of randomized, placebo-controlled clinical trials. Clinical studies have investigated the efficacy of DVS in doses ranging from 50 to 400 mg… More >>

Desvenlafaxine Succinate: A Newer Antidepressant for the Treatment of Depression and Somatic Symptoms

Tags: Antidepressant, Depression, Desvenlafaxine, Newer, Somatic, Succinate, Symptoms, Treatment
Post stats: 0 comments | 63 views

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on June 15, 2000. The length of the article is 608 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Sleep Apnea S… More >>

Sleep Apnea Symptoms Differ in Women vs. Men.: An article from: Family Practice News

Tags: Apnea, article, Differ, Family, from, Men., news..., Practice, Sleep, Symptoms, women.
Post stats: 0 comments | 23 views

Product Description
You’re already an expert on your thyroid symptoms. Why not become an expert on solutions? Although your doctor is an invaluable resource, taking charge of your health care is the best way to discover treatments that work, make the most of your medical appointments, and restore your thyroid balance. Because hypothyroidism, hyperthyroidism, and other thyroid problems affect every woman differently, The Women’s Guide to Complete Thyroid Health takes a persona… More >>

The Women’s Guide to Thyroid Health: Comprehensive Solutions for All Your Thyroid Symptoms

Tags: Comprehensive, Guide, Health, solutions, Symptoms, Thyroid, Women's
Post stats: 2 comments | 38 views